Regional Health Properties Reports Fourth Quarter 2025 Results


Reported Full Year Profitability of $3.4 million

Repurchased 511,099 Series B Preferred Shares

HealthCare Services segment reports 20% growth in Average Daily Census

ATLANTA, GA, April 07, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB:RHEPZ), a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services, today announced its financial results for the fourth quarter ended December 31, 2025.

FOURTH QUARTER 2025 FINANCIAL RESULTS

  • Reported revenue of $20.8 million
  • Generated GAAP net income of $2.7 million and Adjusted EBITDA1 of $1.7 million
  • Reported earnings per share of $.68

TWELVE MONTHS ENDED DECEMBER 31, 2025 FINANCIAL RESULTS

  • Reported revenue of $53.2 million
  • Generated GAAP net income of $ 3.4 million and Adjusted EBITDA of $3.1 million
  • Reported earnings per share of $1.09

FOURTH QUARTER 2025 BUSINESS HIGHLIGHTS

  • Recognized $2.7 million gain on sale of the Coosa Valley facility located in Glencoe, Alabama
  • Portfolio occupancy increased from 70.6% to 72.2%
  • Repurchased 511,099 shares of the Company’s 12.5% Series B Cumulative Redeemable Preferred Shares at a discount to liquidation preference

TWELVE MONTHS ENDED DECEMBER 31, 2025 BUSINESS HIGHLIGHTS

  • For the Healthcare Services segment,
    • Average Daily Census (“ADC”) rose from 389 to 467, a 20% increase
    • Quality Mix² rose from 9.1% to 12.2%
  • Portfolio occupancy increased from 62.5% to 72.2%

MANAGEMENT COMMENTS

Brent Morrison, Regional’s President, Chief Executive Officer and Chairman, commented, “We are proud of the meaningful progress Regional team made in 2025. The merger with SunLink significantly broadened our healthcare platform, while the sale of a non-core asset demonstrated our continued focus on disciplined capital allocation. Taken together, these milestones reflect a year of execution and strategic progress for the Company”.

Mr. Morrison continued, “We believe the operational progress we are making across our facilities will be a key driver of Regional’s future growth. We are encouraged by the progress achieved in 2025 and remain optimistic that we will continue to build on this momentum in 2026.”

BALANCE SHEET AND LIQUIDITY

As of December 31, 2025, the Company had $44.0 million of outstanding indebtedness with a weighted-average annual interest rate of 5.06% and a weighted-average maturity of approximately 15 years. For the twelve months ended December 31, 2025, net cash used by operating activities was $2.3 million.

About Regional Health Properties, Inc.

Regional Health Properties, Inc. is a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services. For more information, visit https://www.regionalhealthproperties.com.

Important Cautions Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expects,” “intends,” “believes,” “anticipates,” “plans,” “likely,” “will,” “seeks,” “estimates” and variations of such words and similar expressions are intended to identify such forward-looking statements. This press release includes forward-looking statements that reflect the Company’s current views with respect to, among other things, its business, operations, financial performance and revenue; use of sales proceeds; and future strategy.

Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: our dependence on the operating success of our operators; the amount of, and our ability to service, our indebtedness; covenants in our debt agreements that may restrict our ability to make investments, incur additional indebtedness and refinance indebtedness on favorable terms; the availability and cost of capital; our ability to raise capital through equity and debt financings or through the sale of assets; increases in market interest rates and inflation; the effect of increasing healthcare regulation and enforcement on our operators and the dependence of our operators on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; the impact of litigation and rising insurance costs on the business of our operators; the impact on us of litigation relating to our prior operation of our healthcare properties; the effect of our operators declaring bankruptcy, becoming insolvent or failing to pay rent as due; the ability of any of our operators in bankruptcy to reject unexpired lease obligations and to impede our ability to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations; our ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; epidemics or pandemics, and the related impact on our tenants, operators and healthcare facilities; and other factors discussed from time to time in our news releases, public statements and documents filed by us with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto or any other change in events, conditions, or circumstances on which any such statement is based, except to the extent otherwise required by applicable law.

Company Contact

Brent Morrison, CFA
Chief Executive Officer & President
Regional Health Properties, Inc.
Tel (678) 368-4402
Brent.morrison@regionalhealthproperties.com

REGIONAL HEALTH PROPERTIES, INC.        
STATEMENT OF OPERATIONS        
(in thousands)

  Quarter Ending December 31, 
  2025  2024 
Revenues:      
Patient care revenues $11,803  $ 3,855 
Rental revenues  1,268    1,748 
Pharmacy revenues  7,704     
Other revenues      57 
Total revenues  20,775    5,660 
Expenses:        
Cost of goods sold  4,512     
Patient care expense  10,561    2,980 
Facility rent expense  228    148 
Depreciation and amortization  712    563 
General and administrative expense  3,666    1,323 
Loss on lease termination  559     
Credit loss expense  159    105 
Gain on operations transfer       
Total expenses  20,397    5,119 
Gain on asset sale  (2,706)    
Income from operations  3,084    541 
Other (income) expense:        
Interest expense, net  652    689 
Gain on bargain purchase  (464)    
Other expense, net  197    420 
Total other (income) expense, net  385    1,109 
Net income (loss)  2,699    (568)
Preferred stock dividends       
Deemed contribution related to Preferred Series B purchases       
Net profit (loss) attributable to Regional Health Properties, Inc. common stockholders  2,699    (568)
Unrecognized net gain on pension assets  22     
Comprehensive income $2,677   -$568 
Net profit (loss) per share of common stock attributable to Regional Health Properties, Inc.:        
Basic $0.68   -$0.31 
Diluted $0.68   -$0.31 
Weighted average shares of common stock outstanding:        
Basic  3,945    1,858 
Diluted  3,945    1,858 


REGIONAL HEALTH PROPERTIES, INC.

STATEMENT OF OPERATIONS
(in thousands)

  Year Ended December 31, 
  2025  2024 
Revenues:      
Patient care revenues $36,050  $11,273 
Rental revenues  5,402   7,005 
Pharmacy revenues  11,708    
Other revenues     57 
Total revenues  53,160   18,335 
Expenses:        
Cost of goods sold  6,982    
Patient care expense  30,785   9,442 
Facility rent expense  780   594 
Depreciation and amortization  2,063   2,062 
General and administrative expense  12,041   5,408 
Loss on lease termination  862    
Credit loss expense  795   668 
Gain on operations transfer  (106)   
Total expenses  54,202   18,174 
Gain on asset sale  (2,706)   
Income from operations  1,664   161 
Other (income) expense:        
Interest expense, net  2,671   2,710 
Gain on bargain purchase  (5,775)   
Other expense, net  1,398   669 
Total other (income) expense, net  (1,706)  3,379 
Net income (loss)  3,370   (3,218)
Preferred stock dividends  (603)   
Deemed contribution related to Preferred Series B purchases  278    
Net profit (loss) attributable to Regional Health Properties, Inc. common stockholders  3,045   (3,218)
Unrecognized net gain on pension assets  22    
Comprehensive income $3,067  $(3,218)
Net profit (loss) per share of common stock attributable to Regional Health Properties, Inc.:        
Basic $1.09  $(1.73)
Diluted $1.09  $(1.73)
Weighted average shares of common stock outstanding:        
Basic  2,805   1,858 
Diluted  2,805   1,858 


  Maturity  Interest Rate  Principal  % of Principal  Deferred financing costs  Unamortized discount on bonds  Net Carrying Value 
                      
Total Fixed Rate Debt  5/21/2042   4.34%  36,876   83.9%  (636)  (101)  36,140 
                             
Total Floating Rate Debt  10/1/2036   8.42%  7,084   16.1%  (71)  -   7,013 
                             
Total         $43,960   100.0% $(706) $(101) $43,153 


Use of Non-GAAP Financial Measures

This press release presents information about EBITDA and Adjusted EBITDA, which are non-GAAP financial measures provided as a supplement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Company believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance by excluding certain items that may not be indicative of its recurring core business operating results. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning and forecasting future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to the Company’s historical performance. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.

These non-GAAP financial measures are presented for supplemental informational purposes only. These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as a substitute for, GAAP financial measures. These non-GAAP financial measures may differ from the non-GAAP financial measures used by other companies. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measure is provided below for each of the fiscal periods indicated.

A reconciliation of EBITDA and Adjusted EBITDA is as follows:

REGIONAL HEALTH PROPERTIES, INC.
RECONCILIATION OF NET LOSS TO NON-GAAP FINANCIAL MEASURES
(in thousands)

  Quarter Ended  Quarter Ended  Quarter Ended  Quarter Ended  Year Ended 
(Amounts in 000’s) 3/31/2025  6/30/2025  9/30/2025  12/31/2025  Total 
Net income (loss) $(1,263) $(1,449) $3,381  $2,700  $3,370 
Depreciation and amortization  402   403   546   712   2,063 
Interest expense, net  653   615   751   652   2,671 
Amortization of employee stock compensation  22   25   124   62   233 
Provision for income tax  -   -   -   -   - 
EBITDA $(186) $(406) $4,803  $4,126  $8,337 
Credit loss expense  70   400   166   159   795 
Loss on lease termination  303   -   -   559   862 
Gain on asset sale  -   -   -   (2,706)  (2,706)
Gain on bargain purchase  -   -   (5,311)  -   (5,311)
Adjustments to gain on bargain purchase  -   -   -   (464)  (464)
Gain on operations transfer  (106)  -   -   -   (106)
Merger costs  261   357   584   84   1,285 
Other one-time costs  110   86   181   (11)  366 
Tail insurance on legacy facilities  56   18   -   -   74 
Adjusted EBITDA from operations $508  $455  $423  $1,747  $3,132 



1 Adjusted EBITDA is a non-GAAP financial measure. See “Use of Non-GAAP Financial Measures” for important additional information.
² Figures omit Meadowood since it is all private pay


GlobeNewswire